A 58-year-old man with heart failure (EF 30%) remains symptomatic (NYHA II) on ACE inhibitor and beta-blocker. K+ 4.6 mmol/L, eGFR 68. Next disease-mo...

Question

A 58-year-old man with heart failure (EF 30%) remains symptomatic (NYHA II) on ACE inhibitor and beta-blocker. K+ 4.6 mmol/L, eGFR 68. Next disease-modifying therapy?

Accepted Answer

Add mineralocorticoid receptor antagonist

Answer

Add loop diuretic only

Answer

Start ivabradine immediately

Answer

Start digoxin

Answer

Switch ACE inhibitor to hydralazine alone

ukmla MCQ (SBA): Heart failure therapy optimisation

A 58-year-old man with heart failure (EF 30%) remains symptomatic (NYHA II) on ACE inhibitor and beta-blocker. K+ 4.6 mmol/L, eGFR 68. Next disease-modifying therapy?